# GANX (Gain Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Gain Therapeutics, Inc. reported $13.23M in total assets and a net loss of $17.98M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/GANX
- Markdown: https://convexityos.com/fundamentals/GANX.md
- SEC CIK: 0001819411
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:53 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001819411&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$17.70M | Operating profit |
| Net Income | FY 2025 | -$17.98M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.41 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $11.70M | Total debt: $677K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $55K | $140K | $165K | $29K |
| Research & Development | $10.21M | $10.79M | $11.52M | $8.38M | $7.16M | $2.26M |
| Total Operating Expenses | $18.71M | $20.35M | $22.31M | $17.92M | $13.99M | $3.51M |
| **Operating Income** | -$18.71M | -$20.35M | -$22.25M | -$17.78M | -$13.83M | -$3.48M |
| **EBITDA** | -$18.62M | -$20.27M | -$22.17M | -$17.71M | -$13.81M | -$3.47M |
| Interest Expense | -- | -- | -- | -- | $0 | -- |
| Income Before Tax | -$19.30M | -$19.87M | -$22.19M | -$17.50M | -$13.89M | -$3.57M |
| Income Tax Expense | $861K | $537K | $79K | $93K | $4.0K | $5.4K |
| **Net Income** | -$20.16M | -$20.41M | -$22.27M | -$17.59M | -$13.89M | -$3.58M |
| Basic EPS | -$0.61 | -$0.89 | -$1.71 | -$1.48 | -$1.37 | -$1.33 |
| **Diluted EPS** | -$0.61 | -$0.89 | -$1.71 | -$1.48 | -$1.37 | -$1.33 |
| Basic Shares Outstanding | 33.0M | 22.9M | 13.0M | 11.9M | 10.2M | 2.7M |
| Diluted Shares Outstanding | 33.0M | 22.9M | 13.0M | 11.9M | 10.2M | 2.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.42M | $2.14M | $2.76M | $2.35M | $2.85M | $2.76M | $2.26M | $1.22M |
| Total Operating Expenses | $3.20M | $4.68M | $5.35M | $4.47M | $4.79M | $5.09M | $4.37M | $3.33M |
| **Operating Income** | -$3.20M | -$4.68M | -$5.35M | -$4.47M | -$4.79M | -$5.09M | -$4.37M | -$3.33M |
| **EBITDA** | -$3.18M | -$4.65M | -$5.33M | -$4.44M | -$4.76M | -$5.07M | -$4.35M | -$3.31M |
| Income Before Tax | -$3.09M | -$4.57M | -$5.43M | -$4.47M | -$4.74M | -$5.67M | -$4.43M | -$3.26M |
| Income Tax Expense | $72K | $104K | $183K | $70K | $549K | $141K | $101K | $505K |
| **Net Income** | -$3.16M | -$4.68M | -$5.61M | -$4.54M | -$5.28M | -$5.81M | -$4.53M | -$3.77M |
| Basic EPS | -$0.07 | -$0.11 | -$0.13 | -- | -$0.15 | -$0.19 | -$0.16 | -- |
| **Diluted EPS** | -$0.07 | -$0.11 | -$0.13 | -- | -$0.15 | -$0.19 | -$0.16 | -- |
| Basic Shares Outstanding | 43.8M | 42.9M | 42.2M | -- | 35.0M | 30.3M | 28.7M | -- |
| Diluted Shares Outstanding | 43.8M | 42.9M | 42.2M | -- | 35.0M | 30.3M | 28.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $20.84M | $10.39M | $11.79M | $7.31M | $36.88M | $7.49M |
| Short-Term Investments | -- | -- | $5.00M | $12.83M | -- | -- |
| **Cash & Short-Term Investments** | $20.84M | $10.39M | $16.80M | $20.14M | $36.88M | $7.49M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | $8.5K |
| **Total Current Assets** | $22.24M | $11.60M | $17.78M | $21.09M | $37.72M | $8.99M |
| Property, Plant & Equipment, Net | $75K | $104K | $126K | $144K | $106K | $30K |
| Intangible Assets | $103K | -- | -- | -- | -- | -- |
| Long-Term Investments | -- | -- | -- | $1.94M | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | -- | $52K |
| **Total Non-Current Assets** | $582K | $521K | $830K | $3.01M | $1.26M | $617K |
| **Total Assets** | $22.82M | $12.12M | $18.61M | $24.10M | $38.99M | $9.60M |
| Accounts Payable | $825K | $946K | $1.32M | $1.63M | $560K | $962K |
| Short-Term Debt | $101K | $110K | $119K | $108K | $104K | $23K |
| Other Current Liabilities | $2.31M | $2.44M | $2.16M | $2.11M | $1.40M | $768K |
| **Total Current Liabilities** | $3.35M | $3.91M | $4.95M | $4.13M | $2.55M | $2.11M |
| Long-Term Debt | $300K | $328K | $449K | $495K | $590K | $716K |
| **Total Non-Current Liabilities** | $902K | $873K | $1.08M | $1.09M | $1.61M | $1.29M |
| **Total Liabilities** | $4.25M | $4.78M | $6.03M | $5.22M | $4.17M | $3.40M |
| **Total Debt (incl. Leases)** | $732K | $653K | $1.03M | $1.27M | $1.61M | $1.26M |
| Common Stock | $4.2K | $2.7K | $1.6K | $1.2K | $1.2K | $354 |
| Retained Earnings | -$101.4M | -$60.78M | -$38.52M | -$20.93M | -$7.03M | -$3.46M |
| Accumulated Other Comp. Income | $777K | -$248K | $247K | $36K | -$91K | -$153K |
| **Total Stockholders' Equity** | $18.56M | $7.34M | $12.58M | $18.88M | $34.82M | $6.20M |
| Total Equity | $18.56M | $7.34M | $12.58M | $18.88M | $34.82M | $6.20M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.70M | $13.08M | $16.54M | $20.84M | $8.81M | $6.69M | $9.07M | $10.39M |
| **Cash & Short-Term Investments** | $11.70M | $13.08M | $16.54M | $20.84M | $8.81M | $6.69M | $9.07M | $10.39M |
| **Total Current Assets** | $12.70M | $14.97M | $18.22M | $22.24M | $10.52M | $9.31M | $11.15M | $11.60M |
| Property, Plant & Equipment, Net | $40K | $47K | $54K | $75K | $86K | $96K | $98K | $104K |
| Intangible Assets | $66K | -- | -- | $103K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $534K | $452K | $517K | $582K | $454K | $527K | $473K | $521K |
| **Total Assets** | $13.23M | $15.42M | $18.74M | $22.82M | $10.97M | $9.83M | $11.62M | $12.12M |
| Accounts Payable | $603K | $1.22M | $1.52M | $825K | $1.58M | $2.71M | $2.15M | $946K |
| Short-Term Debt | $120K | $124K | $100K | $101K | $126K | $126K | $113K | $110K |
| Other Current Liabilities | $1.49M | $1.98M | $2.15M | $2.31M | $2.34M | $2.20M | $2.40M | $2.44M |
| **Total Current Liabilities** | $2.37M | $3.43M | $3.89M | $3.35M | $4.17M | $5.20M | $5.03M | $3.91M |
| Long-Term Debt | $189K | $220K | $273K | $300K | $299K | $325K | $314K | $328K |
| **Total Non-Current Liabilities** | $712K | $696K | $845K | $902K | $892K | $941K | $816K | $873K |
| **Total Liabilities** | $3.08M | $4.13M | $4.73M | $4.25M | $5.06M | $6.14M | $5.84M | $4.78M |
| **Total Debt (incl. Leases)** | $677K | $610K | $672K | $732K | $605K | $681K | $607K | $653K |
| Common Stock | $4.4K | $4.3K | $4.2K | $4.2K | $3.6K | $3.1K | $2.9K | $2.7K |
| Retained Earnings | -$114.8M | -$111.6M | -$101.4M | -$101.4M | -$81.19M | -$81.19M | -$81.19M | -$60.78M |
| Accumulated Other Comp. Income | $873K | $1.00M | $997K | $777K | $563K | $584K | -$120K | -$248K |
| **Total Stockholders' Equity** | $10.15M | $11.29M | $14.01M | $18.56M | $5.91M | $3.70M | $5.78M | $7.34M |
| Total Equity | $10.15M | $11.29M | $14.01M | $18.56M | $5.91M | $3.70M | $5.78M | $7.34M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$20.16M | -$20.41M | -$22.27M | -$17.59M | -$13.89M | -$3.58M |
| Depreciation & Amortization | $94K | $84K | $84K | $64K | $15K | $9.6K |
| Stock-Based Compensation | $1.80M | $2.39M | $3.26M | $1.53M | $839K | $82K |
| Change in Working Capital | -$1.01M | -$1.08M | $442K | $1.51M | -$330K | -- |
| Change in Receivables | -- | -- | -- | -- | $8.3K | -$196 |
| Change in Payables | -- | -- | -$643K | $1.07M | -$521K | $396K |
| **Operating Cash Flow** | -$18.47M | -$18.87M | -$18.87M | -$14.69M | -$12.37M | -$3.24M |
| Capital Expenditure | -- | -$22K | -$15K | -$119K | -$94K | -$21K |
| **Free Cash Flow** | -- | -$18.90M | -$18.88M | -$14.81M | -$12.46M | -$3.26M |
| Purchases of Investments | -- | -- | -$1.96M | -$17.74M | -- | -- |
| **Investing Cash Flow** | -- | $4.98M | $10.22M | -$14.77M | -$94K | -$21K |
| **Financing Cash Flow** | $28.45M | $13.01M | $12.64M | -$79K | $41.77M | $10.49M |
| **Net Change in Cash** | $10.46M | -$1.41M | $4.49M | -$29.57M | $29.41M | $7.19M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.16M | -$4.68M | -$5.61M | -$4.54M | -$5.28M | -$5.81M | -$4.53M | -$3.77M |
| Depreciation & Amortization | $19K | $27K | $21K | $28K | $23K | $22K | $21K | $21K |
| Stock-Based Compensation | $376K | $566K | $404K | $402K | $460K | $522K | $420K | $359K |
| Change in Working Capital | -$224K | -$698K | $226K | -$522K | -$136K | -$508K | $159K | -$621K |
| **Operating Cash Flow** | -$3.05M | -$4.68M | -$4.73M | -$4.62M | -$4.93M | -$5.10M | -$3.82M | -$3.45M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$43K |
| **Financing Cash Flow** | $1.75M | $1.37M | $404K | $16.55M | $7.03M | $2.47M | $2.40M | $2.31M |
| **Net Change in Cash** | -$1.39M | -$3.46M | -$4.30M | $12.03M | $2.11M | -$2.37M | -$1.31M | -$1.67M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -40328.3% | -12688.1% | -8379.8% | -12047.5% |
| **Net Profit Margin** | -- | -- | -40354.3% | -12555.1% | -8418.9% | -12387.7% |
| Return on Equity (ROE) | -108.6% | -278.1% | -177.0% | -93.2% | -39.9% | -57.7% |
| Return on Assets (ROA) | -88.4% | -168.4% | -119.7% | -73.0% | -35.6% | -37.3% |
| Current Ratio | 6.63x | 2.97x | 3.59x | 5.11x | 14.78x | 4.25x |
| Quick Ratio | 6.22x | 2.66x | 3.39x | 4.88x | 14.45x | 3.55x |
| Debt to Equity | 0.04x | 0.09x | 0.08x | 0.07x | 0.05x | 0.20x |
| **Revenue Growth (YoY)** | -- | -- | -60.6% | -15.1% | +471.3% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -177.2% | -178.1% | -151.6% | -108.6% | -328.1% | -503.1% | -362.1% | -278.1% |
| Return on Assets (ROA) | -135.9% | -130.4% | -113.3% | -88.4% | -176.7% | -189.1% | -180.0% | -168.4% |
| Current Ratio | 5.36x | 4.36x | 4.69x | 6.63x | 2.52x | 1.79x | 2.22x | 2.97x |
| Quick Ratio | 4.94x | 3.81x | 4.26x | 6.22x | 2.11x | 1.29x | 1.80x | 2.66x |
| Debt to Equity | 0.07x | 0.05x | 0.05x | 0.04x | 0.10x | 0.18x | 0.10x | 0.09x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
